iCeutica
3602 Horizon Dr, Suite 160
King of Prussia, PA 19406
T: 610-382-5610
E: info@iceutica.com
or bd@iceutica.com
iCeutica
works with pharmaceutical partners to create new branded medicines by combining
our proprietary SoluMatrix™ Fine Particle Technology with our partners’ product
experience and commercial insights.
SoluMatrix™ Fine Particle Technology
The SoluMatrix technology is a scalable
and cost-effective manufacturing process that can produce submicron-sized drug
particles that are 10 to 200 times smaller than conventional drug particles.
The technology both grinds the drug particles into a superfine powder and
protects those submicron particles from subsequent agglomeration. The resulting
powder can be manufactured into tablets, capsules, and other dosage forms using
standard pharmaceutical unit operations.
The SoluMatrix technology has been applied
at commercial-scale and three products utilizing the technology have been
approved by FDA.
How
SoluMatrix Works
The
SoluMatrix technology improves the performance of lipophilic and poorly water
soluble pharmaceuticals by dramatically increasing the rate of drug dissolution
and improving oral absorption. By making submicron-sized particles of a drug,
it is possible to:
- Improve
the bioavailability and reduce the pharmacokinetic variability of a drug
- Reduce the
time to onset of therapeutic efficacy
- Reduce the
amount of drug required to achieve a desired plasma level
-
Reduce or
eliminate food effects
- Change the
mode of administration of a drug
What
SoluMatrix Can Do For Your Product
Using the SoluMatrix technology,
iCeutica can transform development-stage or marketed pharmaceutical products in
a number of clinically relevant and commercially important ways. For poorly
soluble or highly variable products in development, we can ensure the product
successfully progresses through clinical development and that the patient
receives a consistent dose of the drug, with potentially less drug required and
fewer side effects experienced. For marketed products, we can unleash improved
performance and new intellectual property protection that extends the product
lifecycle and profitability of the product.
Services
iCeutica also provides companies development
services, leveraging our staff of experienced industry professionals.
We offer the ability
to be your single service provider to manage all steps of drug development from
Phase 1 to NDA submission. Our development services
include:
- Dosage
Form Development
- Regulatory
Submissions
- GMP
Manufacturing Managemen
- Clinical
Study Management
Our
teams are led and staffed by experienced industry professionals and we can
rapidly move from concept to clinical trial material to advance your drug
development program.
Popularity:This record has been viewed
13802 times.